EXAM #3: MDS/MPD Flashcards

(57 cards)

1
Q

What is MDS? What are the general characteristics of MDS?

A

MDS= Myelodysplastic Syndrome

  • Dysplasia or bad growth of the bone marrow cells
  • Increased number of cells i.e. hypercellular bone marrow with poor products
  • Results in various cytopenias (low numbers)
  • Blasts less than 20% in the bone marrow

Greater than 20% blasts= leukemia*

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the major etiology of MDS?

A

Most myelodysplasias result from de novo mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What causes secondary MDS?

A
  • Genetic factors
  • Environmental factors
  • Antineoplastic drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the signs and symptoms of MDS?

A
  • Anemia
  • Infection
  • Bleeding
  • Organomegaly/ Lymphadenopathy
  • Sweet’s Syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is Sweet’s Syndrome?

A

Acute febrile neutrophilic dermatosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How is MDS diagnosed?

A

Bone marrow biopsy

PBS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are some of the cell types seen on PBS that are typical of MDS?

A

1) Giant platelets
2) Pseudo-Pegler Huet anomaly
3) Ringed Sideroblasts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

List the differential diagnoses of MDS.

A
  • Vitamin B12 and Folate Deficiency
  • Viral infection e.g. HIV
  • Chemotherapy
  • Alcohol
  • Lead toxicity
  • Benzene
  • Erythropoietic agents e.g. EPO or G-CSF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What types of chemotherapeutic agents cause MDS?

A
  • Alkylating agents

- Topoisomerase inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which class of chemotheraputic drugs can more quickly cause lead to MDS?

A

Topoisomerase inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which class of chemotheraputic drugs more commonly leads to MDS?

A

Alkylating agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is 5q-Syndrome? What patient population is this seen in?

A

Subtype of MDS that causes:

  • Macrocytic anemia
  • Luekopenia
  • Platelet counts elevated

This is seen in FEMALES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the prognosis for 5q Syndrome?

A

Good

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What drug is used to treat 5q Syndrome?

A

Lenalidomide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is CMML?

A

Chronic Myelomonocytic Leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the characteristics of CMML?

A
  • Increased monocytes

- Variable degrees of dysplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What drugs can be used to treat CMML?

A

Imatinib

Azaytidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is hypocellular MDS?

A

MDS with clinical features that resemble aplastic anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is low intensity treatment for MDS?

A
  • Supportive care
  • Transfusion
  • Growth factor support
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is high intensity treatment for MDS?

A
  • Stem cell transplant
  • Chemotherapy
  • Clinical trials
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the “growth factors” that are used to treat MDS?

A

G-CSF
GM-CSF
EPO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

When does EPO tend to work better in patients with MDS?

A

When EPO level is already less than 500

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

In patients with MDS, what class of drugs have been shown to decrease time to leukemia and transfusion dependence?

A

Hypomethylating agents i.e. Azacytidine

24
Q

What is the role of transplant in the treatment of MDS? What type of transplant is curative?

A

Allogeneic transplant is curative; however, patients have to be less than 40

25
What is a myeloproliferative disorder?
Overproduction of one or more blood cell line
26
What are the classic myeloproliferative disorders?
1) Chronic myeloid leukemia 2) Polycythemia vera 3) Essential thrombocytosis 4) Primary myelofibrosis
27
What mutation is seen with PV and ET?
JAK2
28
What is the mutation seen in CML?
t(9:22) BCR-ABL
29
What are the symptoms of CML?
``` Fatigue Night sweats Weight loss Splenomegaly Anemia Platelet dysfunction ```
30
What are the labs that are characteristic of CML?
1) BASOPHILIA 2) Leukocytosis 3) Neutrophilia
31
What are the three phases of CML?
Chronic Accelerated Blast
32
What are the characteristics of the chronic phase of CML?
Basophilia Blasts less than 10 BCR-ABL
33
What is the hallmark of the acclerated phase of CML?
Worsened splenomegaly
34
What is the blast phase of CML?
Greater than 20% blasts i.e. transformation to Leukemia
35
How is CML diangosed?
1) BCR-ABL 2) Basophilia 3) Confirm with FISH or RT-BCR
36
What is the primary treatment for CML? What class of drug is this?
Imatinib, a tyrosine kinase inhibitor
37
What is the second line treatment for CML when patients are resistant to Imatinib?
Dasatinib
38
What causes resistance to Imatinib?
Mutations in the ABL kinase domain
39
What is Polycythemia Vera?
Elevated RBC mass with concomitant increase in WBC and platelets
40
What are the symptoms associated with PV?
1) Puritis, especially after bathing 2) Headache 3) Blurry vision 4) Venous thrombosis-->Budd Chiari
41
What are the major diagnostic criteria for PV?
- High Hb with JAK2 mutation | - 18.5 in men, and 16.5 women
42
What are the minor criteria for PV?
- Bone marrow hypercellulatiry | - Low serum EPO
43
What does diagnosis of PV require?
- BOTH major and 1 minor | - 1 major and BOTH minor
44
What is the first line treatment for PV?
Phlebotomy and low dose ASA
45
For patients with PV and intermediate risk/ high risk, what is the second line treatment?
Cytoreductive therapy i.e. hydroxyurea
46
When is hydroxurea contraindicated?
Pregnancy
47
What is Essential Thrombocytosis?
Isolated increased in platelet count
48
What are the clinical features of ET?
- Visual disturbance - Dizziness - HA - Erythromelalgia - Cutaneous ulcers - Thrombosis (venous or arterial) - Hemorrhage
49
What are the diagnostic criteria for ET?
1) Platelet count greater than 450,000 2) BM biopsy with proliferation of megakaryocytic lineage 3) JAK2 mutation or ruled out reactive thrombocytosis
50
What are the cause of secondary thrombocytosis?
``` Iron deficiency Infection Inflammation Surgery Trauma Tissue injury/infarction Malignancy S/p splenectomy ```
51
How is ET treated?
Hydroxyurea--first line | Anagrelide
52
What is Primary Myelofibrosis?
Proliferation of mature myeloid cells i.e. megakaryoctes that produce PDGF, causing bone marrow fibrosis
53
What is the worst of the myeloproliferative disorders?
Primary myelofibrosis
54
What are the hallmarks of Primary Myelofibrosis?
- Bone marrow fibrosis | - Extramedullary hematopoesis
55
What are the clinical features of Primary Myelofibrosis?
Splenogmegaly
56
How is Primary Myelofibrosis treated?
Palliation and support
57
What are the supportive measures that are commonly undertaken in Primary Myelofibrosis?
1) Recombinant EPO 2) Iron chelation 3) Splenectomy 4) JAK2 5) Allo SCT